Mark Shearman

Overview

Mark Shearman received $4M in total compensation, including $253K in salary, at Editas Medicine in 2021.

Source: SEC filing on April 26, 2022.

Related executives

We found 12 more executives who work or worked at Editas Medicine.

James Mullen

Editas Medicine

Chief Executive Officer

Michelle Robertson

Editas Medicine

Chief Financial Officer

Bruce Eaton

Editas Medicine

Executive Vice President and Chief Business Officer

Lisa Michaels

Editas Medicine

Chief Medical Officer

Cynthia Collins

Editas Medicine

Chief Executive Officer

Charles Albright

Editas Medicine

Chief Scientific Officer

Judith Abrams

Editas Medicine

Chief Medical Officer

Eric Ek

Editas Medicine

Chief Financial Officer

News

You may also like